La literatura identifica este compuesto como Body Protection Compound-157 y lo estudia en modelos preclnicos de reparacin de tejido blando
Unfortunately, long-standing suppliers like Strate Labs reduce availability or exit the market
FDA Peptide Regulation GHK-Cu FDA Status and Compounding Update 2026: What Anti-Aging Patients Should Know Newtropin Team FDA UPDATE GHK-Cu FDA Status and Compounding Update 2026: What Anti-Aging Patients Should Know Published May 11, 2026 Newtropin Editorial Team Last Updated: May 2026 The GHK-Cu FDA status in 2026 presents one of the most nuanced regulatory situations in the current peptide landscape
Sources: Sonnenburg, E., & Sadeghi, K
PMID 29986520
Second, although we adjusted for various confounding factors (age, sex, diabetes duration, alcohol use, Hb, and DPN), potential factors that could have a confounding effect remained, such as race/ethnicity, stress, and dietary habits